{"id":"https://openalex.org/W2575454267","doi":"https://doi.org/10.1200/jop.2016.014639","title":"Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications","display_name":"Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications","publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W2575454267","doi":"https://doi.org/10.1200/jop.2016.014639","mag":"2575454267","pmid":"https://pubmed.ncbi.nlm.nih.gov/28095170","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6366250"},"language":"en","primary_location":{"id":"doi:10.1200/jop.2016.014639","doi":"https://doi.org/10.1200/jop.2016.014639","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jop.2016.014639","pdf_url":null,"source":{"id":"https://openalex.org/S131102849","display_name":"Journal of Oncology Practice","issn_l":"1554-7477","issn":["1554-7477","1935-469X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6366250","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029035012","display_name":"Chan Shen","orcid":"https://orcid.org/0000-0001-5680-3134","observed_orcids":["https://orcid.org/0000-0001-5680-3134"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chan Shen","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003661484","display_name":"Bo Zhao","orcid":"https://orcid.org/0000-0001-7602-0874","observed_orcids":["https://orcid.org/0000-0001-7602-0874"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bo Zhao","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110936835","display_name":"Lei Liu","orcid":"https://orcid.org/0009-0005-9457-683X","observed_orcids":["https://orcid.org/0009-0005-9457-683X"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Liu","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071831846","display_name":"Ya\u2010Chen Tina Shih","orcid":"https://orcid.org/0000-0001-7290-3864","observed_orcids":["https://orcid.org/0000-0001-7290-3864"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ya-Chen Tina Shih","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX; and Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.3693,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.96636791,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"13","issue":"2","first_page":"e152","last_page":"e162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.9919999837875366},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.875},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.6880000233650208},{"id":"https://openalex.org/keywords/patient-financial-burden","display_name":"patient financial burden","score":0.6690000295639038},{"id":"https://openalex.org/keywords/cost-sharing","display_name":"cost sharing","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8752737045288086},{"id":"https://openalex.org/C2776291444","wikidata":"https://www.wikidata.org/wiki/Q6806635","display_name":"Medicare Part D","level":4,"score":0.7271074056625366},{"id":"https://openalex.org/C84265765","wikidata":"https://www.wikidata.org/wiki/Q193219","display_name":"Subsidy","level":2,"score":0.5677100419998169},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.49340739846229553},{"id":"https://openalex.org/C145097563","wikidata":"https://www.wikidata.org/wiki/Q1148747","display_name":"Payment","level":2,"score":0.4874480068683624},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.48293063044548035},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.463013619184494},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3864653706550598},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.16098260879516602},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.15740734338760376},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.1394311487674713},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11777064204216003},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.07561931014060974},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C34447519","wikidata":"https://www.wikidata.org/wiki/Q179522","display_name":"Market economy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D005102","descriptor_name":"Health Expenditures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017047","descriptor_name":"Cost Sharing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018426","descriptor_name":"SEER Program","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054524","descriptor_name":"Medicare Part D","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1200/jop.2016.014639","doi":"https://doi.org/10.1200/jop.2016.014639","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jop.2016.014639","pdf_url":null,"source":{"id":"https://openalex.org/S131102849","display_name":"Journal of Oncology Practice","issn_l":"1554-7477","issn":["1554-7477","1935-469X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Practice","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5363019","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6366250","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6366250","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6366250","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Oncol Pract","raw_type":"Text"},{"id":"pmid:28095170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28095170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology practice","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5363019","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6366250","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2961162582","display_name":"Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs","funder_award_id":"R01CA207216","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7486600206","display_name":"INNOVATIVE METHODS FOR MODELING LONGITUDIANL MEDICAL COSTS","funder_award_id":"R01HS020263","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"}],"funders":[{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W31217916","https://openalex.org/W53781188","https://openalex.org/W1972362505","https://openalex.org/W1976294525","https://openalex.org/W1984023073","https://openalex.org/W1984959392","https://openalex.org/W1998861351","https://openalex.org/W2036482755","https://openalex.org/W2041837876","https://openalex.org/W2050618903","https://openalex.org/W2063050425","https://openalex.org/W2092164194","https://openalex.org/W2093051330","https://openalex.org/W2099090260","https://openalex.org/W2099354636","https://openalex.org/W2105250776","https://openalex.org/W2106042291","https://openalex.org/W2107779395","https://openalex.org/W2113554766","https://openalex.org/W2115724268","https://openalex.org/W2140974115","https://openalex.org/W2153508262","https://openalex.org/W2154835844","https://openalex.org/W2157008749","https://openalex.org/W2164902648","https://openalex.org/W2171331269","https://openalex.org/W2193292762","https://openalex.org/W2402880145","https://openalex.org/W2416286649","https://openalex.org/W2418898752","https://openalex.org/W2513403311","https://openalex.org/W2529061634","https://openalex.org/W4249759551"],"related_works":["https://openalex.org/W2610433949","https://openalex.org/W4295755029","https://openalex.org/W4281829124","https://openalex.org/W2891813761","https://openalex.org/W2193292762","https://openalex.org/W2891596298","https://openalex.org/W2980297255","https://openalex.org/W2406558598","https://openalex.org/W2337449062","https://openalex.org/W2418898752"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,16,174,184],"number":[2],"of":[3,19,27,39,115,129,138,145,162,216,220,234],"targeted":[4],"oral":[5],"anticancer":[6],"medications":[7],"(TOAMs)":[8],"has":[9],"grown":[10],"rapidly":[11],"in":[12,33,150,165],"the":[13,24,40,58,78,85,116,126,136,205,210,217,223,231,241],"past":[14],"decade.":[15],"high":[17,218],"cost":[18,106],"TOAMs":[20,86,123],"raises":[21],"concerns":[22],"about":[23],"financial":[25,228,242],"aspect":[26],"treatment,":[28],"especially":[29],"for":[30,177],"patients":[31,46,76,118,146,178,192],"enrolled":[32],"Medicare":[34,64,131],"Part":[35,65,132],"D":[36,66,133],"plans":[37],"because":[38],"coverage":[41,206],"gap.":[42],"METHODS:":[43],"We":[44,73,110],"identified":[45],"with":[47,63,119,141,172,179,193],"chronic":[48],"myeloid":[49],"leukemia":[50],"(CML)":[51],"who":[52,121],"were":[53,189],"new":[54],"TOAM":[55],"users":[56],"from":[57,68,204],"SEER":[59],"registry":[60],"data":[61],"linked":[62],"data,":[67],"years":[69],"2007":[70],"to":[71],"2012.":[72],"followed":[74],"these":[75],"throughout":[77],"calendar":[79],"year":[80,137],"when":[81,168],"they":[82,169],"started":[83],"taking":[84,97],"and":[87,93,105,194,202],"examined":[88],"their":[89,100,130],"out-of-pocket":[90],"(OOP)":[91],"payments":[92,167],"gross":[94,186],"drug":[95,187],"costs,":[96],"into":[98],"account":[99],"benefit":[101,134],"phase,":[102],"plan":[103],"type,":[104],"share":[107],"group.":[108],"RESULTS:":[109],"found":[111],"that":[112],"726":[113],"(81%)":[114],"898":[117],"CML":[120],"received":[122],"had":[124],"reached":[125],"catastrophic":[127],"phase":[128,149],"within":[135],"medication":[139],"initiation,":[140],"a":[142,153,159,163,214],"large":[143],"majority":[144],"reaching":[147],"this":[148],"less":[151],"than":[152],"month.":[154],"Patients":[155,198],"without":[156,195],"subsidies":[157,180],"showed":[158],"clear":[160],"pattern":[161],"spike":[164],"OOP":[166,175],"began":[170],"treatment":[171,235],"TOAMs.":[173,221],"payment":[176],"was":[181],"substantially":[182],"lower.":[183],"monthly":[185],"costs":[188],"similar":[190],"between":[191],"subsidies.":[196],"CONCLUSION:":[197],"experience":[199],"quick":[200],"entry":[201],"exit":[203],"gap":[207],"(also":[208],"called":[209],"donut":[211,224],"hole)":[212],"as":[213],"result":[215],"price":[219],"Closing":[222],"hole":[225],"will":[226,237],"provide":[227],"relief":[229],"during":[230],"initial":[232],"month(s)":[233],"but":[236],"not":[238],"completely":[239],"eliminate":[240],"burden.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-01-26T00:00:00"}